Beranda › Kanker Prostat › Michigan › Wyoming
Uji klinis Kanker Prostat di Wyoming, MI
4 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Wyoming (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Menerima pesertaFase 3
- Cancer And Hematology Centers Of Western Michigan, Holland · 22 mi jauhnya
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Menerima pesertaFase 3
- University of Michigan Health - West, Wyoming
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Michigan Health - West, Wyoming
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- University of Michigan Health - West, Wyoming
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Wyoming
- Kolitis Ulseratif7 studi
- Penyakit Crohn6 studi
- Kanker Payudara6 studi
- Kanker Paru Non-Sel Kecil6 studi
- Kanker Kolorektal6 studi
- Melanoma6 studi
- Stroke5 studi
- Kanker Kolon5 studi
- Kanker Paru5 studi
- Kanker Kandung Kemih4 studi
- Penyakit Pencernaan4 studi
- Kanker Pankreas3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.